MCHP Investors, You Need to Know These Facts Today.

By Tamara Parker • Tuesday, November 14 12:39 • Permanent Link

Large-cap Technology company Microchip Technology has moved 5.9% so far today on a volume of 2,397,233, compared to its average of 4,568,023. In contrast, the S&P 500 index moved 2.0%.

Microchip Technology trades -8.71% away from its average analyst target price of $88.91 per share. The 22 analysts following the stock have set target prices ranging from $73.0 to $110.0, and on average have given Microchip Technology a rating of buy.

Anyone interested in buying MCHP should be aware of the facts below:

Microchip Technology's current price is 148.5% above its Graham number of $32.67, which implies that at its current valuation it does not offer a margin of safety
Microchip Technology has moved 6.0% over the last year, and the S&P 500 logged a change of 14.0%
Based on its trailing earnings per share of 4.56, Microchip Technology has a trailing 12 month Price to Earnings (P/E) ratio of 17.8 while the S&P 500 average is 15.97
MCHP has a forward P/E ratio of 16.9 based on its forward 12 month price to earnings (EPS) of $4.81 per share
The company has a price to earnings growth (PEG) ratio of 1.13 — a number near or below 1 signifying that Microchip Technology is fairly valued compared to its estimated growth potential
Its Price to Book (P/B) ratio is 6.3 compared to its sector average of 6.23
Microchip Technology Incorporated develops, manufactures, and sells smart, connected, and secure embedded control solutions in the Americas, Europe, and Asia.
Based in Chandler, the company has 22,600 full time employees and a market cap of $43.92 Billion. Microchip Technology currently returns an annual dividend yield of 1.9%.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.